These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28143530)

  • 1. A first immunohistochemistry study of transketolase and transketolase-like 1 expression in canine hyperplastic and neoplastic mammary lesions.
    Burrai GP; Tanca A; Cubeddu T; Abbondio M; Polinas M; Addis MF; Antuofermo E
    BMC Vet Res; 2017 Jan; 13(1):38. PubMed ID: 28143530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular proliferative and telomerase activity in canine mammary gland tumors.
    Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
    Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein expression in benign and malignant canine mammary gland tumours.
    Erginsoy SD; Sozmen M; Caldin M; Furlanello T
    Res Vet Sci; 2006 Aug; 81(1):46-50. PubMed ID: 16289156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands.
    Torres LN; Matera JM; Vasconcellos CH; Avanzo JL; Hernandez-Blazquez FJ; Dagli ML
    Vet Pathol; 2005 Sep; 42(5):633-41. PubMed ID: 16145209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary report on the expression of leptin and leptin receptor (ObR) in normal, hyperplastic and neoplastic canine mammary tissues.
    Ressel L; Finotello R; Innocenti VM; Vannozzi I; Poli A
    Res Vet Sci; 2012 Aug; 93(1):343-9. PubMed ID: 21875727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
    Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
    Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAD51 protein expression is increased in canine mammary carcinomas.
    Klopfleisch R; Schütze M; Gruber AD
    Vet Pathol; 2010 Jan; 47(1):98-101. PubMed ID: 20080488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
    Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
    J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?
    Zavlaris M; Angelopoulou K; Vlemmas I; Papaioannou N
    Anticancer Res; 2009 Jan; 29(1):319-25. PubMed ID: 19331168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 expression in canine mammary tumors.
    Doré M; Lanthier I; Sirois J
    Vet Pathol; 2003 Mar; 40(2):207-12. PubMed ID: 12637762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of parathyroid hormone-related protein in canine mammary tumors.
    Okada H; Nishijima Y; Yoshino T; Grone A; Capen CC; Rosol TJ
    Vet Pathol; 1997 Jul; 34(4):356-9. PubMed ID: 9240847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
    Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
    Ferreira E; Gobbi H; Saraiva BS; Cassali GD
    Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
    Langbein S; Zerilli M; Zur Hausen A; Staiger W; Rensch-Boschert K; Lukan N; Popa J; Ternullo MP; Steidler A; Weiss C; Grobholz R; Willeke F; Alken P; Stassi G; Schubert P; Coy JF
    Br J Cancer; 2006 Feb; 94(4):578-85. PubMed ID: 16465194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in normal canine mammary gland and in mammary tumours and their correlation with oestrogen receptors.
    Nerurkar VR; Ishwad CS; Seshadri R; Naik SN; Lalitha VS
    J Comp Pathol; 1990 Feb; 102(2):191-5. PubMed ID: 2324341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 in canine mammary tumours.
    Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
    J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer.
    Semilia M; Hennenlotter J; Pavone C; Bischoff T; Kühs U; Gakis G; Bedke J; Stenzl A; Schwentner C; Todenhöfer T
    World J Urol; 2015 Oct; 33(10):1403-9. PubMed ID: 25572961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
    Faustino AM; van Garderen E; Schalken JA; Nederbragt H
    J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.